Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 64,520 | 0 | 0 | N/A |
| Receivables | 85,128 | 0 | 0 | N/A |
| Inventories | 27,326 | 0 | 0 | N/A |
| TOTAL | $183,033 | $0 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 4,489 | 0 | 0 | N/A |
| Investments And Advances | 3,308 | 0 | 0 | 0 |
| Intangibles | 266,310 | 0 | 0 | 0 |
| Other Non-Current Assets | 15,267 | 0 | 0 | 0 |
| TOTAL | $289,374 | $N/A | $N/A | $N/A |
| Total Assets | $472,407 | $0 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 10,000 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 6,440 | 0 | 0 | 0 |
| Accrued Expenses | 68,374 | 0 | 0 | N/A |
| Other current liabilities | 4,201 | 0 | 0 | N/A |
| TOTAL | $89,015 | $0 | $0 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 187,965 | 0 | 0 | N/A |
| Other Non-Current Liabilities | 46,489 | 0 | 0 | 0 |
| TOTAL | $237,775 | $N/A | $N/A | $N/A |
| Total Liabilities | $326,790 | $0 | $0 | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -141,700 | 0 | 0 | N/A |
| Other shareholders' equity | 287,317 | 0 | 0 | 0 |
| TOTAL | $145,617 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $472,407 | $0 | $0 | $0 |